Literature DB >> 2024596

Detection of silent myocardial ischemia in diabetes mellitus.

A Langer1, M R Freeman, R G Josse, G Steiner, P W Armstrong.   

Abstract

The prevalence of silent myocardial ischemia and its relation to autonomic dysfunction and pain threshold was studied in 58 men with diabetes mellitus and without cardiac symptoms. All patients underwent 48-hour ambulatory electrocardiographic monitoring and exercise testing after assessment of their autonomic function and pain threshold. Silent myocardial ischemia, defined as greater than or equal to 1 mm of ST-segment depression on either exercise testing or ambulatory electrocardiographic monitoring, was corroborated by exercise-induced reversible defect(s) on tomographic thallium scintigraphy. Autonomic function was assessed by heart rate response to: (1) Valsalva maneuver, (2) deep breathing, and (3) upright posture, as well as by diastolic blood pressure response to sustained handgrip and systolic blood pressure response to upright posture. Autonomic dysfunction was defined as greater than or equal to 2 abnormal responses. Pain threshold measurements were performed using electrical cutaneous stimulation of both forearms. Of the 58 diabetic patients, 21 were found to have autonomic dysfunction (36%). Silent myocardial ischemia was detected in 10 patients (17%), and was significantly more frequent in patients with than without autonomic dysfunction (38 vs 5%, p = 0.003). There was no difference in the electrical pain threshold or tolerance in subjects with and without silent myocardial ischemia. It is concluded that silent myocardial ischemia in asymptomatic diabetic men occurs frequently and in association with autonomic dysfunction, suggesting that diabetic neuropathy may be implicated in the mechanism of silent myocardial ischemia.

Entities:  

Mesh:

Year:  1991        PMID: 2024596     DOI: 10.1016/0002-9149(91)90868-l

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  27 in total

Review 1.  Diagnostic and prognostic value of ambulatory ECG (Holter) monitoring in patients with coronary heart disease: a review.

Authors:  C Michael Gibson; Lauren N Ciaglo; Matthew C Southard; Shaun Takao; Caitlin Harrigan; Jason Lewis; Jason Filopei; Michelle Lew; Sabina A Murphy; Jacqueline Buros
Journal:  J Thromb Thrombolysis       Date:  2007-04       Impact factor: 2.300

2.  Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factors.

Authors:  Yasuaki Hayashino; Sizuko Nagata-Kobayashi; Takeshi Morimoto; Kenji Maeda; Takuro Shimbo; Tsuguya Fukui
Journal:  J Gen Intern Med       Date:  2004-12       Impact factor: 5.128

Review 3.  Single-photon emission computed tomography myocardial perfusion imaging in patients with diabetes.

Authors:  Gavin L Noble; Gary V Heller
Journal:  Curr Cardiol Rep       Date:  2005-03       Impact factor: 2.931

4.  Autonomic dysfunction is related to impaired pancreatic beta cell function in patients with coronary artery disease.

Authors:  J W Sayer; B Marchant; S V Gelding; J A Cooper; A D Timmis
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

Review 5.  [Significance of silent myocardial ischemia for identification and optimal therapy of patients with latent coronary heart disease. Is there a marker for prognostic indication for PTCA?].

Authors:  D Hering; H P Schultheiss; D Horstkotte
Journal:  Herz       Date:  1999-02       Impact factor: 1.443

6.  Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial.

Authors:  Gilles R Dagenais; Jiang Lu; David P Faxon; Peter Bogaty; Dale Adler; Francisco Fuentes; Jorge Escobedo; Ashok Krishnaswami; James Slater; Robert L Frye
Journal:  J Am Coll Cardiol       Date:  2013-02-19       Impact factor: 24.094

Review 7.  Diagnosis of CAD in patients with diabetes: who to evaluate.

Authors:  Lawrence H Young; Powell Jose; Deborah Chyun
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

8.  Prevalence and predictors of an abnormal stress myocardial perfusion study in asymptomatic patients with type 2 diabetes mellitus.

Authors:  Arthur J H A Scholte; Joanne D Schuijf; Antje V Kharagjitsingh; Petra Dibbets-Schneider; Marcel P Stokkel; Ernst E van der Wall; Jeroen J Bax
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-05       Impact factor: 9.236

9.  Symptoms across the continuum of acute coronary syndromes: differences between women and men.

Authors:  Holli A DeVon; Catherine J Ryan; Amy L Ochs; Moshe Shapiro
Journal:  Am J Crit Care       Date:  2008-01       Impact factor: 2.228

10.  Early detection of asymptomatic coronary artery disease in patients with type 2 diabetes mellitus.

Authors:  Won Sang Yoo; Hee Jin Kim; Dohee Kim; Myung Yong Lee; Hyun-Kyung Chung
Journal:  Korean J Intern Med       Date:  2009-08-26       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.